BARD1 may be of potential interest for innovative therapeutics since it seems to be implicated in the pathophysiology of BC and the processes behind cancer cell chemoresistance [124], enabling the assessment of the mechanisms of drug resistance in breast tumors. The gene discussed is BARD1; the disease is breast cancer.